SE7613588L - Forfarande for framstellning av 3,4-dihydro-kinazolinderivat - Google Patents

Forfarande for framstellning av 3,4-dihydro-kinazolinderivat

Info

Publication number
SE7613588L
SE7613588L SE7613588A SE7613588A SE7613588L SE 7613588 L SE7613588 L SE 7613588L SE 7613588 A SE7613588 A SE 7613588A SE 7613588 A SE7613588 A SE 7613588A SE 7613588 L SE7613588 L SE 7613588L
Authority
SE
Sweden
Prior art keywords
dihydro
procedure
preparation
derivatives
chinazoline derivatives
Prior art date
Application number
SE7613588A
Other languages
English (en)
Swedish (sv)
Inventor
G Doria
C Romeo
P Giraldi
F Lauria
M L Corno
P Sberze
M Tibolla
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of SE7613588L publication Critical patent/SE7613588L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/93Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7613588A 1975-12-05 1976-12-03 Forfarande for framstellning av 3,4-dihydro-kinazolinderivat SE7613588L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT29998/75A IT1050750B (it) 1975-12-05 1975-12-05 Derivati della 3.4 di idro chinazolina

Publications (1)

Publication Number Publication Date
SE7613588L true SE7613588L (sv) 1977-06-06

Family

ID=11228830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613588A SE7613588L (sv) 1975-12-05 1976-12-03 Forfarande for framstellning av 3,4-dihydro-kinazolinderivat

Country Status (22)

Country Link
US (1) US4251531A (da)
JP (1) JPS5271485A (da)
AT (1) AT355029B (da)
AU (1) AU505660B2 (da)
BE (1) BE848696A (da)
CA (1) CA1084051A (da)
CH (2) CH626073A5 (da)
CS (1) CS194786B2 (da)
DE (1) DE2654215A1 (da)
DK (1) DK147855C (da)
FI (1) FI64359C (da)
FR (1) FR2333511A1 (da)
GB (1) GB1523081A (da)
HU (1) HU177817B (da)
IL (1) IL50849A (da)
IT (1) IT1050750B (da)
NL (1) NL7613450A (da)
NO (1) NO146095C (da)
NZ (1) NZ182778A (da)
SE (1) SE7613588L (da)
SU (1) SU786894A3 (da)
ZA (1) ZA766745B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
IL69274A (en) * 1982-08-05 1986-08-31 Erba Farmitalia (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
JP4554816B2 (ja) * 1998-05-22 2010-09-29 アボット・ラボラトリーズ ガン、関節炎および網膜症を処置するための抗血管形成薬
US6632961B1 (en) * 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
CN1518447A (zh) * 2001-04-23 2004-08-04 �������Ǵ�ѧר������� 作为抗血管生成剂的新的苯邻二甲酰亚胺模拟物的合成和评估
SI1631295T1 (sl) * 2003-06-06 2010-06-30 Arexis Ab Uporaba kondenziranih heterocikličnih spojin kotSCCE inhibitorjev za zdravljenje kožnih bolezni
CN100518740C (zh) * 2003-06-06 2009-07-29 阿里克斯股份公司 杂环化合物作为scce抑制剂的制药用途
AU2007282678B2 (en) * 2006-08-08 2012-09-27 Aska Pharmaceutical Co., Ltd. Quinazoline derivative
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
KR101913109B1 (ko) 2009-03-18 2018-10-31 리스버로직스 코퍼레이션 신규한 소염제
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
GB201510254D0 (en) * 2015-06-12 2015-07-29 Syngenta Participations Ag Improvements in or relating to organic compounds
BR112020026637A2 (pt) * 2018-06-27 2021-03-30 Reborna Biosciences, Inc. Agente profilático ou terapêutico para atrofia muscular espinhal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3696102A (en) 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones
GB1301319A (da) 1970-07-13 1972-12-29

Also Published As

Publication number Publication date
CH626075A5 (da) 1981-10-30
NO146095B (no) 1982-04-19
AT355029B (de) 1980-02-11
AU505660B2 (en) 1979-11-29
DK546776A (da) 1977-06-06
CA1084051A (en) 1980-08-19
ZA766745B (en) 1977-10-26
GB1523081A (en) 1978-08-31
IL50849A (en) 1980-11-30
FR2333511A1 (fr) 1977-07-01
CS194786B2 (en) 1979-12-31
NO146095C (no) 1982-08-11
JPS5271485A (en) 1977-06-14
ATA894376A (de) 1979-07-15
BE848696A (fr) 1977-03-16
NO764135L (da) 1977-06-07
AU1947276A (en) 1978-05-18
DK147855C (da) 1985-06-10
DE2654215A1 (de) 1977-06-16
DK147855B (da) 1984-12-24
FI64359B (fi) 1983-07-29
IT1050750B (it) 1981-03-20
FR2333511B1 (da) 1979-03-02
HU177817B (en) 1981-12-28
US4251531A (en) 1981-02-17
CH626073A5 (da) 1981-10-30
NL7613450A (nl) 1977-06-07
IL50849A0 (en) 1977-01-31
NZ182778A (en) 1978-07-28
SU786894A3 (ru) 1980-12-07
JPS5543464B2 (da) 1980-11-06
FI763391A7 (da) 1977-06-06
FI64359C (fi) 1983-11-10

Similar Documents

Publication Publication Date Title
SE7613588L (sv) Forfarande for framstellning av 3,4-dihydro-kinazolinderivat
IT1075017B (it) Procedimento per il trattamento di estratti antocianinici
NO154344C (no) Analogifremgangsmaate for fremstilling av antivirale amin- og amidin-derivater.
NO155885C (no) Analogifremgangsmaate for fremstilling av tiazolderivater med anti-ulcus-egenskaper.
IT1057250B (it) Derivati del 6..7 benzomorfano e procedimento per la loro preparazione
SE7603791L (sv) Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner
MX3743E (es) Procedimiento para la preparacion de derivados 3,4-dihidro-2 (lh)-quinazolinona
PT66089B (en) Process for preparing 1,2-benzisothiazolin-3-ona with anti-thrombotic effect application of same for the preparationof pharmaceutical compositions with anti-thrombic effect and application of these pharmaceutical compositions for the treatment of thrombosis
SE433353B (sv) Analogiforfarande for framstellning av pyrido/1,2-a/pyrimidiner med antiflogistisk och koagulationshemmande verkan
BE854485R (fr) Composition empechant une croissance de l'encrassement
IT8021795A0 (it) Derivati del 5h-furanone-2 e del3h-diidrofuranone-2,loro procedimento di preparazione e loro applicazione terapeutica.
AR204390A1 (es) Procedimiento de preparacion de derivados de imidazolidinonas y perhidropirimidinonas n,n' bisustituidas
SE7605940L (sv) Forfarande for framstellning av homo- och sampolymerisat av tetrafluoreten
SE7813277L (sv) Komposition och sett for behandling av hypertension
BG43187A3 (bg) Метод за получаване на ауронови производни
SE407937B (sv) Forfarande for framstellning av 1,3,4-substituerade 2-pyrrolidoner med terapentiska egenskaper
BE846956A (fr) Derives de 1-carbamoyl-k-fluorouracile et leur utilisation comme agents antineoplasiques,
AR215851A1 (es) Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma
IT1039349B (it) Metodo per la preparazione del 2 idrossibenzantrone e dei suoi derivati di sostituzione
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
MX144463A (es) Composicion pigmentaria de 2,9-dicloroquinacridona
NO142444C (no) Fremgangsmaate for fremstilling av foretrede melamin-formaldehydharpikser i vandig opploesning
SE7610834L (sv) Forfarande for framstellning av pastastrengsprutbara polymerisat av tetrafluoreten
SE7611952L (sv) Forfarande for framstellning av aroyl-fenylinden- och aroyl-fenylnaftalenderivat anvendbara sasom antifertilitetsmedel
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7613588-8